Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bin-Yan Zhong

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Cardiovascular and Interventional Radiology|March 29, 2019
Bariatric Arterial Embolization for Overweight Patients: A New Exploration for Ideal Patients?Bin-Yan Zhong
Med (New York, N.Y.)|June 12, 2026
Resectability redefined: Lessons from quadruple therapy in HCCNan Jiang, Bin-Yan Zhong
Cardiovascular and Interventional Radiology|June 7, 2018
Bariatric Arterial Embolization for Obesity: A Review of Early Clinical EvidenceBin-Yan Zhong, Godwin Abiola, Clifford R Weiss
Obesity Surgery|September 6, 2018
Response to Letter of "Left Gastric Artery Embolization for Weight Loss-a Deadend Procedure"Zhi-Bin Bai, Bin-Yan Zhong, Gao-Jun Teng
Chinese Medical Journal|March 22, 2019
Research progress of bariatric embolization for treatment of obesityBin-Yan Zhong, Pei-Cheng Li, Cai-Fang Ni
Journal of Vascular and Interventional Radiology : JVIR|September 2, 2020
Changes in IR from 2007 to 2017 in ChinaBin-Yan Zhong, Cai-Fang Ni, Gao-Jun Teng
Journal of Clinical and Translational Hepatology|September 5, 2022
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published EvidenceShen Zhang, Wan-Sheng Wang, Bin-Yan Zhong, et al.
Pain Physician|March 25, 2017
Reply to: Percutaneous Vertebral Augmentation for the Treatment of Symptomatic Schmorl's Nodes: Our Viewpoint and ExperienceShi-Cheng He, Bin-Yan Zhong, Hai-Dong Zhu, et al.
World Journal of Gastrointestinal Surgery|August 18, 2022
Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-propositionShen Zhang, Bin-Yan Zhong, Lei Zhang, et al.
Radiology|March 7, 2017
Early Sorafenib-related Biomarkers for Combination Treatment with Transarterial Chemoembolization and Sorafenib in Patients with Hepatocellular CarcinomaBin-Yan Zhong, Cai-Fang Ni, Li Chen, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Cardiovascular and Interventional Radiology|March 29, 2019
Bariatric Arterial Embolization for Overweight Patients: A New Exploration for Ideal Patients?Bin-Yan Zhong
Med (New York, N.Y.)|June 12, 2026
Resectability redefined: Lessons from quadruple therapy in HCCNan Jiang, Bin-Yan Zhong
Cardiovascular and Interventional Radiology|June 7, 2018
Bariatric Arterial Embolization for Obesity: A Review of Early Clinical EvidenceBin-Yan Zhong, Godwin Abiola, Clifford R Weiss
Obesity Surgery|September 6, 2018
Response to Letter of "Left Gastric Artery Embolization for Weight Loss-a Deadend Procedure"Zhi-Bin Bai, Bin-Yan Zhong, Gao-Jun Teng
Chinese Medical Journal|March 22, 2019
Research progress of bariatric embolization for treatment of obesityBin-Yan Zhong, Pei-Cheng Li, Cai-Fang Ni
Journal of Vascular and Interventional Radiology : JVIR|September 2, 2020
Changes in IR from 2007 to 2017 in ChinaBin-Yan Zhong, Cai-Fang Ni, Gao-Jun Teng
Journal of Clinical and Translational Hepatology|September 5, 2022
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published EvidenceShen Zhang, Wan-Sheng Wang, Bin-Yan Zhong, et al.
Pain Physician|March 25, 2017
Reply to: Percutaneous Vertebral Augmentation for the Treatment of Symptomatic Schmorl's Nodes: Our Viewpoint and ExperienceShi-Cheng He, Bin-Yan Zhong, Hai-Dong Zhu, et al.
World Journal of Gastrointestinal Surgery|August 18, 2022
Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-propositionShen Zhang, Bin-Yan Zhong, Lei Zhang, et al.
Radiology|March 7, 2017
Early Sorafenib-related Biomarkers for Combination Treatment with Transarterial Chemoembolization and Sorafenib in Patients with Hepatocellular CarcinomaBin-Yan Zhong, Cai-Fang Ni, Li Chen, et al.
Pageof 8